HealthExec December 19, 2019
Amy Baxter

Several major technology companies have come under scrutiny for being granted access to some patient health data to develop new technologies and tools, but Americans may be more open to sharing their information in the name of innovation for specific purposes.

That’s according to a recent survey from Lantern Pharma that found a majority of Americans would share their health data in the name of drug development and medical research. Specifically, Lantern Pharma surveyed 1,054 Americans on their feelings toward the use of patient and healthcare data in AI and cancer drug development.

Three-quarters of respondents (76%) said they would share their personal health data for medical research, while 88% said they would share it if it helped develop therapies...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Health IT, Market Research, Patient / Consumer, Pharma, Technology, Trends
How can the NHS Federated Data Platform help meet patient needs of today and tomorrow?
FDA targets health inequality by improving at-home devices
Patient Treatment & Travel: The Need for Stepped-Up Support
A reminder for good senior health: How much screen time is too much?
Changes in payer requirements for telehealth since 2019

Share This Article